Dr. Harin Haridas Kanani has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Harin Haridas Kanani, who appears to be a promoter of Neogen Chemicals Limited, has submitted a disclosure to the stock exchange under Regulation 10(5) of the SEBI Takeover Regulations. This regulation specifically deals with disclosures related to the encumbrance (pledge) of shares held by promoters or members of the promoter group. The public filing indicates that some change has taken place regarding shares that were previously pledged, but the announcement text does not specify whether shares were newly pledged, invoked by a lender, or released from an encumbrance. No specific share counts, percentages, or pledge amounts have been disclosed in this filing.
This is a routine compliance filing by a promoter regarding changes in pledged shares, but the exact nature (pledge creation, invocation, or release) is not clear from the filing. Investors should look at the detailed disclosure on the exchange website to understand whether this signals financial stress (invocation) or normal business activity before drawing any conclusions about stock impact.